Clinical Trial Update: A Double-blind, Placebo-controlled Trial of Donepezil Adjunctive Treatment for Cognitive Impairment in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 double-blind, placebo-controlled trial evaluating donepezil as adjunctive treatment for cognitive impairment in schizophrenia. Current status is UNKNOWN…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Central South University | Conditions: Impaired Cognition, Schizophrenia | Phase 4 | Status: UNKNOWN